A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations
Phase 3
2,196
about 2.9 years
4+
157 sites in AL, AZ, CA +30
What this study is about
Researchers are testing whether a fixed dose combination of fluticasone propionate and albuterol sulfate, given as an inhaler, can help prevent severe asthma attacks. The trial will last for up to 35 months and involve adults and children with asthma.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Albuterol sulfate
- 2.Take TEV-56248
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Respiratory System Agent (Adrenergic beta2-Agonists)
inhaled
Secondary: Composite Responders Based on Asthma Quality of Life Questionnaire + 12 (AQLQ+12) or Pediatric AQLQ (PAQLQ), Number of Participants Who Withdrew From the Trial Due to Treatment-Emergent Adverse Events, Number of Participants with at Least One Adverse Event, Number of Participants with at Least One Serious Adverse Event
Respiratory